These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 38966302

  • 21. Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes.
    Nishioka H, Fukuhara N, Horiguchi K, Yamada S.
    J Neurosurg; 2014 Sep; 121(3):505-10. PubMed ID: 25014437
    [Abstract] [Full Text] [Related]

  • 22. Value of Early Post-Operative Growth Hormone Testing in Predicting Long-Term Remission and Residual Disease after Transsphenoidal Surgery for Acromegaly.
    Wang YY, Waqar M, Abou-Zeid A, Kearney T, Caputo C, Davis J, Trainer P, Higham C, Roncaroli F, Gnanalingham KK.
    Neuroendocrinology; 2022 Sep; 112(4):345-357. PubMed ID: 34052822
    [Abstract] [Full Text] [Related]

  • 23. A single-center experience of transsphenoidal endoscopic surgery for acromegaly in 73 patients: results and predictive factors for remission.
    Unal TC, Aydoseli A, Ozgen U, Dolas I, Sabanci PA, Aras Y, Ozturk M, Ozata MS, Gul N, Kubat Uzum A, Mutlu U, Bilgic B, Saka E, Yarman S, Sencer A.
    Br J Neurosurg; 2024 Jun; 38(3):648-653. PubMed ID: 34241568
    [Abstract] [Full Text] [Related]

  • 24. Long-term outcomes of transsphenoidal surgery for management of growth hormone-secreting adenomas: single-center results.
    Asha MJ, Takami H, Velasquez C, Oswari S, Almeida JP, Zadeh G, Gentili F.
    J Neurosurg; 2020 Nov 01; 133(5):1360-1370. PubMed ID: 31604330
    [Abstract] [Full Text] [Related]

  • 25. Endoscopic endonasal transsphenoidal surgery for functional pituitary adenomas.
    Hofstetter CP, Shin BJ, Mubita L, Huang C, Anand VK, Boockvar JA, Schwartz TH.
    Neurosurg Focus; 2011 Apr 01; 30(4):E10. PubMed ID: 21456921
    [Abstract] [Full Text] [Related]

  • 26. Long-Term Endocrine Outcomes Following Endoscopic Endonasal Transsphenoidal Surgery for Acromegaly and Associated Prognostic Factors.
    Babu H, Ortega A, Nuno M, Dehghan A, Schweitzer A, Bonert HV, Carmichael JD, Cooper O, Melmed S, Mamelak AN.
    Neurosurgery; 2017 Aug 01; 81(2):357-366. PubMed ID: 28368500
    [Abstract] [Full Text] [Related]

  • 27. Outcome of Endoscopic Transsphenoidal Surgery for Acromegaly.
    Kim JH, Hur KY, Lee JH, Lee JH, Se YB, Kim HI, Lee SH, Nam DH, Kim SY, Kim KW, Kong DS, Kim YH.
    World Neurosurg; 2017 Aug 01; 104():272-278. PubMed ID: 28465267
    [Abstract] [Full Text] [Related]

  • 28. Long term follow-up of growth hormone-secreting pituitary adenomas submitted to endoscopic endonasal surgery.
    Leopoldo CMDS, Leopoldo FMDS, Santos ARLD, Veiga JCE, Lima JV, Scalissi NM, Lazarini PR, Dolci RLL.
    Arq Neuropsiquiatr; 2017 May 01; 75(5):301-306. PubMed ID: 28591390
    [Abstract] [Full Text] [Related]

  • 29. 2010 versus the 2000 consensus criteria in patients with normalised insulin-like growth factor 1 after transsphenoidal surgery has high predictive values for long-term recurrence-free survival in acromegaly.
    Shen M, Chen Z, Shou X, He W, Qiao N, Ma Z, Ye Z, Zhang Y, Zhang Q, Zhou X, Cao X, Zhang Z, Ye H, Li Y, Zhao Y, Li S, He M, Wang Y.
    J Neuroendocrinol; 2021 May 01; 33(5):e12958. PubMed ID: 33998086
    [Abstract] [Full Text] [Related]

  • 30. Long-Term Effects of Intracapsular Debulking and Adjuvant Somatostatin Analogs for Growth Hormone-Secreting Pituitary Macroadenoma: 10 Years of Experience in a Single Institute.
    Shen SC, Shen CC, Pu TW, Cheng WY.
    World Neurosurg; 2019 Jun 01; 126():e41-e47. PubMed ID: 30716503
    [Abstract] [Full Text] [Related]

  • 31. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center.
    Gondim JA, Almeida JP, de Albuquerque LA, Gomes E, Schops M, Ferraz T.
    Neurosurg Focus; 2010 Oct 01; 29(4):E7. PubMed ID: 20887132
    [Abstract] [Full Text] [Related]

  • 32. Preoperative lanreotide treatment for GH-secreting pituitary adenomas: effect on tumour volume and predictive factors of significant tumour shrinkage.
    Lucas T, Astorga R, Catalá M, Spanish Multicentre Lanreotide Study Group on Acromegaly.
    Clin Endocrinol (Oxf); 2003 Apr 01; 58(4):471-81. PubMed ID: 12641631
    [Abstract] [Full Text] [Related]

  • 33. Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria.
    Hazer DB, Işık S, Berker D, Güler S, Gürlek A, Yücel T, Berker M.
    J Neurosurg; 2013 Dec 01; 119(6):1467-77. PubMed ID: 24074496
    [Abstract] [Full Text] [Related]

  • 34. Endoscopic endonasal approach for acromegaly: surgical outcomes using 2018 consensus criteria for remission.
    de Carvalho Cavalcante RA, Vieira LA, Peres LFA, Zaccariotti AJ, de Sousa Alencar H, Jatene EM, Camargo LA, Dias Rodrigues ML.
    Arch Endocrinol Metab; 2023 Jun 19; 67(6):e000650. PubMed ID: 37364152
    [Abstract] [Full Text] [Related]

  • 35. Endonasal endoscopic surgery in pituitary adenomas: Surgical results in a series of 86 consecutive patients.
    López-García R, Abarca-Olivas J, Monjas-Cánovas I, Picó Alfonso A, Moreno-López P, Gras-Albert JR.
    Neurocirugia (Astur : Engl Ed); 2018 Jun 19; 29(4):161-169. PubMed ID: 29580720
    [Abstract] [Full Text] [Related]

  • 36. Endoscopic endonasal lateral transellar approach for growth hormone-secreting adenomas with cavernous sinus invasion: Technical note and surgical results.
    Gómez-Amador JL, Martínez-Anda JJ, Guerrero-Suarez PD, Rosales-Amaya AM, Delgado-Arce JC, Guerrero-López DA.
    Neurocirugia (Astur : Engl Ed); 2021 Jun 19; 32(4):170-177. PubMed ID: 34218877
    [Abstract] [Full Text] [Related]

  • 37. Surgical results of growth hormone-secreting pituitary adenoma.
    Kim MS, Jang HD, Kim OL.
    J Korean Neurosurg Soc; 2009 May 19; 45(5):271-4. PubMed ID: 19516943
    [Abstract] [Full Text] [Related]

  • 38. [Transsphenoidal surgery of secretory and invasive pituitary adenomas (somatotropinoma or corticotropinoma)--own experiences].
    Zieliński G, Podgórski JK, Koziarski A, Potakiewicz Z, Warczyńska A, Zgliczyński W, Makowska A.
    Przegl Lek; 2004 May 19; 61(9):928-34. PubMed ID: 15803901
    [Abstract] [Full Text] [Related]

  • 39. Intraoperative Scoring System to Predict Postoperative Remission in Endoscopic Endonasal Transsphenoidal Surgery for Growth Hormone-Secreting Pituitary Adenomas.
    Yano S, Shinojima N, Kawashima J, Kondo T, Hide T.
    World Neurosurg; 2017 Sep 19; 105():375-385. PubMed ID: 28602880
    [Abstract] [Full Text] [Related]

  • 40. Transsphenoidal surgery for acromegaly: predicting remission with early postoperative growth hormone assays.
    Sarkar S, Jacob KS, Pratheesh R, Chacko AG.
    Acta Neurochir (Wien); 2014 Jul 19; 156(7):1379-87; discussion 1387. PubMed ID: 24781680
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.